Efficacy and safety of fremanezumab in patients with obesity and difficult-to-treat migraine: Subgroup analysis of the randomized, double-blind, phase 3b FOCUS study
B. Torphy,M. Ortega,L. J. Krasenbaum,X. Ning,M. J. Seminerio,L. Lyras,T. Lengil,H. Akcicek,L. Janka,M. Smith,D. Holle-Lee
